Navigation Links
World $114 Billion Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - Forecasts to 2022 - Research and Markets
Date:4/6/2017

DUBLIN, Apr. 06, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022" report to their offering.

It is anticipated that the global site specific drug delivery market will cross US$ 114 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications, rising chronic disease incidences, and increasing research related activities for exploring drug delivery therapeutic applications.

The advent of site specific/targeted drug delivery has revolutionized the drug delivery industry. This technique is allowing a previously unattainable level of drug delivery with greater efficiency to target organs and tissues. Due to this ability, the share of site specific drug delivery is incessantly increasing in the drug delivery industry.

The major application areas of targeted drug delivery pulmonary, ocular, oncology, and others including CNS, cardiovascular, etc. Oncology based application is the largest area of application of targeted drug delivery. This large share can be attributed to various research related activities conducted for developing targeted drug delivery approach for cancer.

Moreover, the report also contains the market share of major regions, including North America, Europe, and Asia Pacific. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Australia, which is expanding therapeutic applications of site specific drug delivery to brain disorders. North America and Europe are expected to grow at a modest rate due to less stringent regulatory approval process and advancements in drug delivery technique.

The last segment of the report is entirely devoted to profiling leading companies of the targeted drug delivery industry, including some major players like Celgene Corporation, Arrowhead Pharma, Intezyne, Endocyte, BioDelivery Sciences International, PharmaIN, Mirus Bio, Savara, etc.

Market Dynamics

Market Drivers

  • Increasing Complexity of Drug Molecules
  • Need for Improved Site-Specific Drug Delivery
  • Advent of Nanotechnology in Site-Specific Drug Delivery
  • Increasing Investments

Market Restraints

  • Complexity in Biopharma Supply Chain & Operations
  • Issues in Quality Compliance & Regulatory Screening

Market Opportunities

  • Increasing R&D Spending in Site-Specific Drug Delivery Technologies
  • Surging Demand for In-Licensing Drug Delivery Products & Technologies

Companies Mentioned

  • Arrowhead Pharmaceuticals, Inc.
  • BioDelivery Sciences International, Inc.
  • Celgene Corporation
  • Delpor, Inc.
  • Endocyte, Inc.
  • Intezyne, Inc.
  • Kurve Technology, Inc.
  • Mirus Bio LLC.
  • PharmaIN
  • Savara Inc.

For more information about this report visit http://www.researchandmarkets.com/research/fncr9l/sitespecific

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/world-114-billion-site-specific-drug-delivery-market-by-application-pulmonary-ocular-oncology-cns-cardiovascular---forecasts-to-2022---research-and-markets-300436058.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
2. Wireless Pill Bottle Wins Healthcare Innovation World Cup
3. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
4. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
5. Accuray is Honored for Delivering World-Class Customer Service
6. Worldwide Medical Device Market Reports
7. The New York Times and Vook Publish "A WORLD OF HURT: Fixing Pain Medicines Biggest Mistake"
8. Worldwide Orthopaedic Product Sales Reached $43.1 Billion in 2012, States ORTHOWORLDs Newly-released Orthopaedic Industry Report
9. DebMed to Display Clients Increased Hand Hygiene Compliance Rates and Worlds First Monitored Point-of-Care Dispenser at APIC
10. Infusion Pumps Markets Worldwide - Projected to Reach over $7.6 billion by 2018
11. Biosimilars And Follow-On Biologics: World Market 2013-2023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2018)... ... October 12, 2018 , ... ... open, welcoming applications from healthcare providers, students, trainees, and researchers worldwide. Winning proposals ... as microbiome sequencing and bioinformatics services. , “uBiome is thrilled to further expand ...
(Date:10/13/2018)... Fla. (PRWEB) , ... October 13, 2018 , ... In ... period taking on one massive brand after another. 2018 has been a game-changing year ... categories have all played a large role in the growth. Ion Labs attributes its ...
(Date:10/11/2018)... ... 11, 2018 , ... In the last four months it has also obtained ... allowance of six more in USA, China and Japan from three other patent families ... and security products. , The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic ...
Breaking Medicine Technology:
(Date:10/16/2018)... ... October 15, 2018 , ... LGC Maine Standards ... Number 205bf, for easier linearity and calibration verification. , The kit, in ... verification and verification of the reportable range for Albumin (ALB), Amylase (AMY), Cholesterol ...
(Date:10/16/2018)... (PRWEB) , ... October 16, ... ... a Texas-based healthcare and clinical research networking-technology company founded by patient-survivors, and ... quality and compliance in the clinical trial execution process, today announced its ...
(Date:10/13/2018)... ... 2018 , ... Convoy of Hope’s Disaster Services Team is currently in Marianna, ... set up to serve hurricane survivors with water, food, baby products, hygiene kits, flood ... additional truckloads of supplies are in motion to Florida. , Convoy’s walk-up ...
(Date:10/11/2018)... CHURCH, Va. (PRWEB) , ... October 11, 2018 ... ... and services, today announced the acquisition of J.Lodge, an industry leader in contact ... story —a lifelong survivor of a debilitating medical condition—J. Lodge supports alternative work ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... and quite vulnerable to manipulation,” warns former U.S. Department of Homeland Security deputy ... We’re Vulnerable and How We Can Stop it. , Pointing to the ability ...
Breaking Medicine News(10 mins):